AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Uncover the various options for using your credit card points effectively. Make the most of your rewards!
28,235 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Two Harbors moved its special meeting to July 2 to push the CrossCountry Mortgage deal through, while a rival bid fro...
Micron Technology delivered a blockbuster quarter that lifted the chip sector, but investors are already shifting bet...
Eight straight weeks of spot XRP ETF inflows contrast with a falling XRP price, signaling institutional support that ...
Planet Labs leads a broad space sector rally, with Rocket Lab and SpaceX climbing alongside space-focused ETFs as inv...
June’s job gains slowed dramatically to 57,000, with May and April revisions lowering earlier totals. The economy dis...
AMD and Palantir posted contrasting Q1 2026 results, underscoring hardware-led AI growth versus enterprise software a...
A Gulf Coast Florida county is drawing a steady stream of Midwest retirees and remote workers, reshaping housing mark...
Rate expands its mortgage team by bringing 14 loan officers from New American Funding, aiming to boost production and...
Google and Apple are leading the AI stock surge. This piece weighs valuation, growth, and cash flow to answer which m...
Eli Lilly stock could advance in the second half of 2026 as Foundayo gains traction and the GLP-1 franchise shines, b...
Lawmakers are rushing to end the $24,480 earnings limit that reduces Social Security benefits for retirees who keep w...